Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Ibrexafungerp is used in dog for Resistant Candida infections. Routes documented in dog: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Ibrexafungerp in dog, drawn from published veterinary references. Verify against current literature before clinical use.
Trade names: Brexafemme
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 5–10 mg/kg | q12h day 1, then q24h | 1-7 days | Resistant Candida infections | Weak | Plumb's Veterinary Drug Handbook, 9th Ed |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Inhibits beta-1,3-D-glucan synthase at a site distinct from echinocandins. First oral glucan synthase inhibitor. Active against azole- and echinocandin-resistant Candida.
GI upset. Teratogenic — contraindicated in pregnancy. CYP3A4 interactions. Novel mechanism. No veterinary data.
Species-specific contraindications and adverse-reaction reports for dog may differ from canine / feline reference data — consult the primary citations listed with each rule.
Why a species-specific page? Ibrexafungerp pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dog — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.